
Having a master's degree doesn't make you a better worker, say hiring managers—but you'll still get paid more
A master's degree may not lead to better job performance, but employers are still willing to pay extra for employees who have one, according to a new survey.
In a survey of 1,000 hiring managers in the U.S., Resume Genius found that 62% of hiring managers say that employees with master's degrees perform the same — or worse — at work as employees with a bachelor's degree and two years of experience.
Despite this, 72% of hiring managers still say they would offer higher salaries to a job candidate with a master's degree than one without.
Of those hiring managers, 64% would offer a 10% salary increase, 20% would offer a 15% increase, and 23% would offer a 20% or higher salary increase.
So why does a master's degree still command a higher salary?
"I think we're in a transition where the symbolic value of degrees still affects salary decisions, even if employers don't actually think the performance of master's degree holders matched the credentials," says Eva Chan, senior PR expert at Resume Genius.
According to Chan, having a master's degree is often perceived as a sign of potential by hiring managers.
"Even if it doesn't guarantee better performance, it can show that you're very driven, you're disciplined, you're committed, and that you've given your time, money and effort into accomplishing a goal," she says.
However, she says, the survey results demonstrated that "more and more employers are realizing experience can show a lot of these same qualities."
Skills-based hiring has become increasingly common: JP Morgan Chase has eliminated degree requirements for most jobs at the bank, prioritizing work experience over credentials. Walmart is also moving towards skills-based hiring for their corporate roles by adjusting job descriptions to "factor in the skills people possess, alongside any degrees they hold."
Chan says that she and her team were surprised to find that Gen Z hiring managers were twice as likely as Boomer hiring managers to perceive master's degree holders as stronger performers.
In her view, this could be because Gen Z may be more familiar with the school system than the workplace.
"Some younger managers may still be fresh from school, or they just finished their degree so it's fresh in their minds," she says. "Maybe they view advanced degrees as more relevant or even aspirational."
Around 25 million American adults hold master's degrees, according to statistics from the Education Data Initiative, and the number of people pursuing a master's degree doubled between 2000 and 2019.
In addition to higher salaries, having a master's degree can provide several potential benefits for employees, such as opportunities career advancement.
However, those boosts come at a hefty price: on average, getting a master's degree costs more than $62,000, and the average federal loan debt balance for graduate students is over $94,000.
According to Chan, whether or not a master's degree will help your career depends on your individual situation.
Having a master's degree can be helpful in professions like education and urban planning that are "heavily tied to pay scales, promotions or credentials," Chan says.
However, for fast-moving industries such as tech, media and marketing, prioritizing real-world experience may be a better choice.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Hill
an hour ago
- The Hill
Puerto Rico is Trump's perfect partner in reshoring
President Trump recently signed an executive order to bring pharmaceutical manufacturing back to the U.S. by streamlining the process for the Food and Drug Administration to approve pharmaceutical manufacturing plants. This is the latest in the Trump administration's agenda to protect national security and create American jobs by promoting the reshoring of critical supply chains that Americans rely on every day. These efforts are coupled with international tariffs to encourage domestic manufacturing. Reshoring pharmaceutical manufacturing is not only dire for American national security, but it could have resounding economic impacts across the country. One U.S. jurisdiction that is ready and in a perfect position to partner in this effort is Puerto Rico, where pharmaceutical manufacturing is already a more than $50 billion industry. With complementary efforts underway in Congress and on the island, the White House should look to Puerto Rico as America's pharmaceutical powerhouse while not trapping the island in its current territory status by hindering a future transition to statehood that would further boost the island's manufacturing ability. As a territory, the island is part of the U.S. customs zone and is not subject to U.S. tariffs, and everything that is made in Puerto Rico is 'Made in the USA.' Yet, that same territory status has limited Puerto Rico's economic development by creating persistent uncertainty, underinvestment and an unequal playing field for economic competition. The territory status is unpopular on the island, and Puerto Rican voters have voted in favor of statehood four consecutive times, most recently last November. Trump and Congress have the opportunity of a generation to leverage the pharmaceutical infrastructure and workforce in Puerto Rico to achieve their agenda while also turbocharging the economy on the island, and they have the perfect ally in Puerto Rico to do it with — the island's Republican Gov. Jenniffer González-Colón. González-Colón is leading an ambitious agenda to reshape the national narrative about the island and its people — and ultimately achieve statehood for Puerto Rico. Aligning with the Trump administration's vision to reshore advanced manufacturing of critical products, she issued an executive order in late March and reached out to top White House officials to offer Puerto Rico's well-established, yet currently underutilized, manufacturing capacity as an economic engine to help grow American prosperity. González-Colón's executive order promotes the relocation of overseas manufacturing of pharmaceuticals and other products to Puerto Rico. Much like Trump's executive order, it eliminates barriers and streamlines the process for businesses to move to the island. This action is complementary to the Medical Manufacturing, Economic Development and Sustainability Act, which was recently reintroduced and incentivizes pharmaceutical manufacturing on the island and throughout economically distressed zones across the United States. The bill is designed to attract business to the island in a way that invests in the people of Puerto Rico. It does this by providing an incentive for medical manufacturing facilities to relocate to economically distressed zones, with an incentive dependent on the number of jobs created to ensure money is flowing back into communities. The incentive itself is based on economic factors and applies to communities throughout the United States — an appropriately wide scope that comports with Trump's strong desire to reshore large amounts of production in a short time frame. By tethering the tax credits to what manufacturers invest directly into wages, salaries and real middle-class benefits, the proposal creates good-paying, quality American jobs. Reshoring to Puerto Rico would mean that critical pharmaceuticals and medical devices, as well as other products that are currently manufactured overseas in China and other nations, would now be produced in America. This would create thousands of well-paying manufacturing jobs that Puerto Rico needs to turbocharge the modest economic progress it's made in recent years. The increased consumer demand on the island would help boost the approximately $70 billion in annual interstate commerce, resulting in more jobs and profits stateside. Puerto Rico is a natural partner in reshoring the medical and pharmaceutical manufacturing industry within U.S. borders. The island's leaders share in the White House's vision of a more prosperous pharmaceutical manufacturing industry and are working to ensure reshoring efforts do not trap Puerto Rico in its current territory status but instead enable it to reach its full potential as an engine of economic growth and prosperity as a future state of our Union. Manufacturing makes America stronger, especially when it lifts up communities and the hard-working American citizens that make 'Made in the USA' a possibility, including those in Puerto Rico.
Yahoo
an hour ago
- Yahoo
Tinder's new head pushes company to move away from 'hookup' reputation and rebrand for Gen Z users
Spencer Rascoff, the CEO of Tinder parent company Match Group, is promising to change the reputation of Tinder as a casual hookup app into a more serious dating app. "This generation of Gen Z, 18 to 28—it's not a hookup generation. They don't drink as much alcohol, they don't have as much sex," Rascoff said to a group of investors, according to The Wall Street Journal. "We need to adapt our products to accept that reality." Unlike the millennial generation, which helped popularize Tinder and shaped the dating app into a domestic and international success, Gen Z appears to be less interested in purely casual dating experiences. Some commentators believe that Gen Z is a generation that is tired of "ghosting," which is defined as suddenly cutting off communications with another person without warning, and instead seeking more authentic dating experiences. Washington State Democrats Want To Tax Online Dating Apps Rascoff signaled that Gen Z's dating preferences are key to the future success of Tinder as a company. "Users don't want more matches, they want better ones," Rascoff wrote in the memo viewed by The Wall Street Journal. Read On The Fox News App Better matches, according to Rascoff, means fundamentally shifting the way that users interact with Tinder. "Think of Tinder like a bar where people come together to meet new people," Rascoff said. "We have to innovate to drive more people into our establishment, and that means renovating our bar." Rascoff is slated to take the top role at Tinder as well, in a leadership shift that shows the company's attempts to meet changing dating trends for a younger generation of users. How To Not Fall In Love With Ai-powered Romance Scammers While Gen Z struggles with "ghosting" in dating, they also struggle to meet important life milestones like marriage. In the dating world, Gen Zers have access to more potential partners than perhaps any other generation before them. Yet, at the same time, this age group, now between 13-28 years old, is getting married years after their Baby Boomer grandparents did, swiping through potential partners, and going out on dates with multiple people only to face higher rates of article source: Tinder's new head pushes company to move away from 'hookup' reputation and rebrand for Gen Z users
Yahoo
an hour ago
- Yahoo
Cooper Companies Second Quarter 2025 Earnings: EPS Misses Expectations
Revenue: US$1.00b (up 6.3% from 2Q 2024). Net income: US$87.7m (down 1.3% from 2Q 2024). Profit margin: 8.7% (down from 9.4% in 2Q 2024). The decrease in margin was driven by higher expenses. EPS: US$0.44 (down from US$0.45 in 2Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 39%. Looking ahead, revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 8.2% growth forecast for the Medical Equipment industry in the US. Performance of the American Medical Equipment industry. The company's shares are down 13% from a week ago. While earnings are important, another area to consider is the balance sheet. See our latest analysis on Cooper Companies' balance sheet health. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.